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http://www.biomedcentral.com/1471-2334/14/178RESEARCH ARTICLE Open AccessExamining strain diversity and phylogeography in
relation to an unusual epidemic pattern of
respiratory syncytial virus (RSV) in a long-term
refugee camp in Kenya
Charles N Agoti1*, Lillian M Mayieka2, James R Otieno1, Jamal A Ahmed2, Barry S Fields2, Lilian W Waiboci2,
Raymond Nyoka2, Rachel B Eidex2, Nina Marano2, Wagacha Burton2,4, Joel M Montgomery2,4,
Robert F Breiman3,4 and D James Nokes1,5Abstract
Background: A recent longitudinal study in the Dadaab refugee camp near the Kenya-Somalia border identified
unusual biannual respiratory syncytial virus (RSV) epidemics. We characterized the genetic variability of the associated
RSV strains to determine if viral diversity contributed to this unusual epidemic pattern.
Methods: For 336 RSV positive specimens identified from 2007 through 2011 through facility-based surveillance
of respiratory illnesses in the camp, 324 (96.4%) were sub-typed by PCR methods, into 201 (62.0%) group A, 118
(36.4%) group B and 5 (1.5%) group A-B co-infections. Partial sequencing of the G gene (coding for the attachment
protein) was completed for 290 (89.5%) specimens. These specimens were phylogenetically analyzed together with
1154 contemporaneous strains from 22 countries.
Results: Of the 6 epidemic peaks recorded in the camp over the period, the first and last were predominantly made
up of group B strains, while the 4 in between were largely composed of group A strains in a consecutive series of
minor followed by major epidemics. The Dadaab group A strains belonged to either genotype GA2 (180, 98.9%) or
GA5 (2, < 1%) while all group B strains (108, 100%) belonged to BA genotype. In sequential epidemics, strains within
these genotypes appeared to be of two types: those continuing from the preceding epidemics and those newly
introduced. Genotype diversity was similar in minor and major epidemics.
Conclusion: RSV strain diversity in Dadaab was similar to contemporaneous diversity worldwide, suggested both
between-epidemic persistence and new introductions, and was unrelated to the unusual epidemic pattern.
Keywords: Attachment (G) protein, Displaced population, Epidemics, Genetic diversity, Genotype, Refugee, RSVBackground
Displaced populations are reportedly at an increased risk
of morbidity and mortality from acute respiratory infec-
tions [1,2], and viral respiratory pathogens contribute
considerably to this disease burden [3]. Refugees often
live in overcrowded settlements, suffer from malnutri-
tion, can be highly mobile to their country of origin and
into urban centres and frequently receive care from ad* Correspondence: cnyaigoti@kemri-wellcome.org
1Kenya Medical Research Institute (KEMRI)–Wellcome Trust Research
Programme, Kilifi, Kenya
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unless otherwise stated.hoc and under-resourced health service providers [4]. In
addition to the refugees themselves, refugee camps also
host humanitarian aid workers from multiple organiza-
tions and many countries, contributing to uniquely di-
verse social contact patterns for refugees [5]. All of the
above have a potential to modify pathogen diversity and
transmission patterns in refugee camps. Given the con-
sequent high risk for epidemics, it has been proposed
that displaced populations should be given priority for
respiratory infection prevention and control programs
[3,6]. The origins, patterns, and diversity of disease-
causing pathogens occurring in these populations aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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these factors could have implications for the potential
success of the control programs.
In 2007, to quantify the disease burden and under-
stand the prevalence and seasonality of common respira-
tory viral pathogens [3], the Kenya Medical Research
Institute (KEMRI), in collaboration with the United States
Centers for Disease Control and Prevention (CDC),
established respiratory illness surveillance in Kakuma
and Dadaab refugee camps in Kenya [3]. Adenovirus
and respiratory syncytial virus (RSV) were the 2 leading
viral agents identified in patients diagnosed with either
influenza-like illness (ILI) or severe acute respiratory
infection (SARI) [3]. The surveillance in Dadaab camp
revealed the occurrence of biannual peaks of RSV-
associated illness in the camp [3] which was unusual in
that while annual and biennial RSV cycles are observed
elsewhere, we are unaware of any reports of twice
yearly epidemics [7].
RSV clinical isolates can be classified into 2 genetically
and antigenically distinct groups (A and B). These can
be sub-classified into several genotypes within which
further variation has also been documented [8]. Patterns
of dominance in the prevalence of groups A and B have
been observed to cycle in communities during consecu-
tive epidemics (for example, A-A-B, A-A-B, etc..) and
predominant genetic variants within the groups are usu-
ally replaced in successive epidemics [8-10]. These pat-
terns have been hypothesized to reflect the interplay
between the circulating RSV genetic or antigenic diver-
sity and local factors, including herd immunity and so-
cial contact patterns [8]. Due to its notably higher
variation compared with the rest of the RSV genome,
and also being one of the known targets of host protect-
ive immunity [11,12], the gene coding for the RSV at-
tachment (G) protein is frequently targeted in RSV
molecular epidemiology studies [8].
We investigated the RSV group epidemiology and mo-
lecular diversity in the G gene of RSV positive specimens
that were identified at the Dadaab refugee camp from
September 2007 through November 2011. The detected
virus strains were then compared by phylogeny with
those identified globally during the same period (i.e. se-
quences from 22 different countries on 5 continents).
The study aimed to (i) infer whether genetic diversity, at
group and genotype level, played a role in the occur-
rence of the observed biannual epidemic cycles of RSV
in Dadaab; (ii) determine and compare the degree of
variation in the strains that occurred in the camp over
time relative to those that were observed in stable popu-
lations; and (iii) determine the plausible origins of the
strains that were circulating in the camp. Achieving
these aims would increase our understanding on the
mechanisms of RSV persistence in such populations.Methods
Study population
The organization of the Dadaab refugee camp complex
has been described elsewhere in detail [3]. The camp is
located in Garissa County, North Eastern Kenya, about
100 km by road from the Somali border. While more
than 95% of the county’s population is from Somalia, the
refugee population is comprised of people from Somalia
(62%), Sudan (23%), Ethiopia (3%), non-Kenyan east and
central Africa (2.5%), and Kenya (9%). Within the Dadaab
camp complex, sampling was undertaken in Hagadera
(1 of 5 sites making up Dadaab complex). Patients with
ILI were recruited from 1 of 4 health posts (outpatient
clinics) while patients with SARI were recruited from
the only camp hospital. All SARI patients were eligible
for recruitment. The first 3 patients with ILI per day
were also eligible for recruitment. Definitions of SARI and
ILI, described previously [3], were as follows. ILI was de-
fined as fever ≥38°C and cough or sore throat. SARI was
defined as an admission to the hospital with the following
age-specific criteria: (i) for an infant >1 week and <
2 months old, one or more of respiratory rate >60 per
minute, severe chest indrawing, nasal flaring, grunting,
fever ≥38°C, hypothermia < 35.5°C, or pulse oxygen-
ation < 90%; (ii) for a child 2 months to < 5 years of
age, cough or difficulty breathing with one or more of
fast breathing for age (>50/min for a patient 2 months
to < 1 year old or >40/min for children 1 to < 5 years
old), chest indrawing or stridor in a calm child, inability
to drink or breast feed, vomiting, convulsions, lethargy
or unconsciousness, or pulse oxygen saturation < 90%;
(iii) for a patient ≥5 years of age with fever ≥38°C, AND
cough or sore throat, AND shortness of breath or diffi-
culty breathing.
Specimen sampling involved the collection of a naso-
pharyngeal (NP) swab and an oropharyngeal (OP) swab,
inserted into 1 mL of viral transport media (together in
years 1 and 2, and then separately), and stored at 2-8°C
for up to 96 h prior to shipment to the KEMRI-CDC la-
boratory in Nairobi [13]. Informed consent was obtained
from all study participants or their guardians and the
surveillance activities received approval from the Kenya
National Ethical Review Committee and a non-research
determination from CDC [3].
Laboratory procedures
Samples analyzed
As previously described, the samples were initially
screened for multiple respiratory viruses including influ-
enza A and B, RSV, adenovirus, human parainfluenza vi-
ruses (1,2 and 3) and human metapneumovirus using
singleplex real-time (reverse transcriptase [RT]) PCR as-
says [3,13]. The analysis reported here involved RSV
sub-typing into groups A and B, and sequencing of G
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with a cycle threshold (CT) value of 30 or lower were
used as we had previously noted limited success with se-
quencing specimens that had CT values ≥30 for RSV
(CNA personal communication). In the current work,
we defined an “epidemic season” as a period during
which ≥5 RSV cases were identified per month with no
more than 1 month in which < 5 RSV cases were identi-
fied, and an epidemic as major if during the epidemic
period >15 cases were identified during any month.
Viral RNA extraction and sub-typing
Viral RNA was extracted from the specimens using the
QIAmp viral RNA extraction Kit (QIAGEN Ltd) with a
starting sample volume of 140 μL and a final elution
step with 60 μL of elution buffer. Sub-typing for RSV
group A or B was processed through multiplex real-time
RT-PCR, in a one-step fashion, with TaqMan probes that
were specific for either RSV group A or B [14].
G gene amplification and sequencing
Extracted viral RNAs were reverse transcribed and amp-
lified in a one-step reaction protocol (QIAGEN, Ltd)
with primers targeting the entire RSV G gene and part
of the F (fusion protein) gene (AG20 and F164) as previ-
ously described [15]. A microlitre of the resultant prod-
ucts was further amplified in nested PCR procedure with
the primers BG10 and F1 [15]. Details of all primer se-
quences are presented in Additional file 1: Table A1.
Success in amplification was confirmed on a 2% agarose
gel (expected band size of ~830 bp) and the products
purified using the GFX Illustra Kit (GE, Healthcare, UK
Limited) and sequencing done using the BigDye 3.1
Chemistry on the 3130xl Sequencer (Applied Biosystems)
with the nested PCR primers and additional group specific
primers that ensured that all the target nucleotide posi-
tions were sequenced both in the forward and reverse
directions [15]. Contigs were assembled to obtain the
consensus in Sequencher 5.10 (Gene codes corporation,
USA).
Analysis of data
STATA 12 (Statacorp, Texas USA) was used for com-
parison of means (ttest) and proportions (prtest).
Phylogenetic analysis
RSV group A and B sequences were aligned separately in
MAFFT software v6.884b [16]. Alignments were visually
inspected and edited in Se-Al software v2.0 (http://tree.
bio.ed.ac.uk/software/seal/). Phylogenetic analyses to clas-
sify the Dadaab sequences into genotypes and clades were
carried out using MEGA 5 program [17] with trees being
constructed using both Neighbor-joining and Maximum
Likelihood methods. Confidence in branch clusteringpatterns was tested with 1000 bootstrap iterations. Phy-
logeographic analyses were carried out in BEAST 1.7.4
and chain convergence confirmed in Tracer v1.5
(http://tree.bio.ed.ac.uk/software/tracer/) (see Additional
file 1: BEAST analysis). Trees were viewed within MEGA
5 or in Fig Tree program v.1.40 (http://tree.bio.ed.ac.uk/
software/figtree/). Unique sequences are identified as
single or groups of viruses which differ by at least one
nucleotide in their sequenced G gene fragment from all
other virus sequences in a specified location.
Definition of clades and sub-clades
The criteria for naming and assignment of sequences
within the genotypes into further phylogenetically dis-
tinct categories (clades and sub-clades) were similar to
that developed recently for the highly pathogenic avian
influenza virus H5N1 [18]. The classification system pro-
vides information on the Dadaab strains with regard to
the ancestor genotype from which they have diversified,
for instance GA2.1 is a diversified form of GA2. Se-
quences qualified to be grouped into the same phylogen-
etic clade (on comparison of the G gene ectodomain) if
they (i) occurred within the same branch supported by a
bootstrap value of ≥60 (based on 1000 iterations on a
neighbor-joining tree) and (ii) had an average genetic
distance with other clades of >1.5% but an average gen-
etic distance of less than 1.5% within the branch. This
ad hoc clade naming system for Dadaab sequences was
adopted in the absence of a currently existing consensus
on naming RSV clades or new genotypes.
Comparison dataset
Two comparison datasets (for group A and group B)
were compiled from the GenBank sequence database.
These datasets consisted of all sequences from around
the world that were collected from 2006 through 2011
and deemed potential co-circulating strains to those in
Dadaab during the study period. The datasets were fil-
tered to retain sequences whose length spanned the sec-
ond hypervariable region of the RSV G and whose
country of origin and date of collection could be ascer-
tained (see Additional file 1 for information on the filtering
process). The final comparison datasets included sequences
from 22 countries in 5 continents (see Additional file 1:
Table A2), including 3 sequences from Kilifi in coastal
Kenya, 227 sequences from South Africa, and in total 649
sequences for group A and 505 sequences for group B col-
lected from 2006 through 2011.
GenBank accession numbers
The G gene sequences from the Dadaab strains reported
in this study have been deposited into GenBank Database
under the accession numbers KF156341 - KF156630.
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A total of 336 RSV positive specimens collected at the
Dadaab camp from September 2007 through November
2011 met the selection criterion for sub-typing and G
gene sequencing. Of these, 99.7% were Somali, 80.4%
were SARI patients, 56.3% were male, mean (median)
age was 23.6 m (11 m), and mean (median) days of ill-
ness before presentation at health facility was 2.3d (3d).
A comparison of the SARI versus (vs) ILI cases, re-
spectively, showed that SARI cases had a higher propor-
tion of males (57.9% vs 50.0%, P = 0.004) and were of a
younger age (mean months = 17.2 vs 49.8, P ≤ 0.001; me-
dian months = 9 vs 24; under 2 years = 74.8% vs 42.4%,
P ≤ 0.001). However, the number of days of illness before
presentation at a health facility was comparable between
SARI and ILI types (mean = 2.2d vs 2.4d, P = 0.670;
median = 3d vs 3d).
Among the 336 RSV positives, group A and B mono-
infections were detected in 201 (59.8%) and 118 (35.1%)
specimens, respectively, while 5 (1.4%) specimens ap-
peared to be A-B co-infections. The remaining 12 (3.6%)
were negative for both groups (Figure 1). Among the
201 group A infections 177 (88.1%) were successfully se-
quenced, while of the 118 group B infections 108 (91.5%)
were successfully sequenced. All the 5 co-infections se-
quenced for group A G gene but none for group B; hence,
in total there were 182 group A sequences (Table 1).
RSV group temporal patterns
The 5 calendar years of surveillance at the Dadaab camp
documented 6 RSV epidemic peaks, including 4 which
were classified as major (Figure 2 and Table 1). The first
epidemic involved predominantly group B strains and
occurred from November 2007 through February 2008.
This was followed by 4 consecutive epidemics (minor-Samples for 
n= 336
RSV group A
n= 201 (59.8%)
G gene 
sequenced 
n=177 (88%)
RSV group B
n= 118 (35.1%)
G gene 
sequenced  
n=108 (92%)
Figure 1 Summary of results of sub-typing and sequencing of 336 RS
during the surveillance. Note that of 5 co-infections of RSV group A andmajor-minor-major) from April 2008 through February
2010 that were all predominantly associated with group
A strains. Sporadic RSV positive cases were detected
throughout 2010 but with no epidemic peak. Finally, a
major epidemic associated principally with group B
strains occurred after this series of group A epidemics
starting in November 2010 and extending to August
2011 (Figure 2). Notably, during the 4 consecutive group
A peaks, only 2 group B positive specimens were detected
(both in mid- 2009) (Figure 2 and Table 1). Thus the
group dominance pattern over the period was B-a-A-a-A-B
(the lowercase letters represent minor epidemics).
Genetic diversity and clustering of the Dadaab group A
strains
The sequenced 182 Dadaab group A strains (including the
5 co-infections) showed high similarity over the 621 nu-
cleotide region of overlap (nucleotides 301–912 on refer-
ence strain A2, accession number M11486). Throughout
the study period only 28.6% (52/182) of these strains gave
a unique sequence. A mean genetic distance of 1.2% was
calculated for the whole Dadaab group A dataset, and
2.4% for the unique sequences alone. The number of
unique sequences among the specimens sequenced for
each epidemic peak ranged between 2 and 15 (median 10)
and the proportion unique declined with number se-
quenced (Table 1). Within the previously described group
A genotype classification (GA1-GA7, SAA1), 180 (98.9%)
of the Dadaab group A strains fell into the GA2 genotype,
with the 2 remaining stains (1.1%) falling into the GA5
genotype (Figure 3).
The Dadaab GA2 strains diversified into 2 main clusters
(branches on the tree) that met our clade definition, and
were named clade GA2 (2.1) and GA2 (2.2) (see Figure 3).
The GA2 (2.2) clade is closely related to the NA1 (a GA2analysis
RSV group A/B
n= 5 (1.4%) 
RSV group ND
n= 12 (3.6%)
G gene sequenced 
Group A n=5 (100%) 
Group B n=0 (0%)
V positive Dadaab samples that were selected from 2007–11
B, only group A sequences were obtained.
Table 1 Distribution of RSV specimens by group and epidemic (peak month), Dadaab, NE Kenya
Peak Month$ RSV group A§ RSV group B§
Identified (%)* Sequenced Unique (%) % GD¶ Identified Sequenced Unique (%) %GD¶
Jan 2008# 6 (14) 3 2 (67) 4.3 36 24 9 (38) 1.0
Jun 2008 34 (100) 22 10 (45) 5.9 0 - - -
Dec 2008# 66 (100) 66 12 (18) 0.6 0 - - -
Jun 2009 29 (94) 24 13 (54) 0.7 2 2 2 (100) 1.8
Dec 2009# 56 (100) 52 15 (29) 0.7 0 - - -
Mar 2011# 7 (8) 8 4 (50) 0.2 78 76 25 (33) 2.6
Inter-epidemic 8 (53) 7 6 (86) 2.7 7 6 5 (83) 2.4
Total§ 206 (65.6) 182 62 (34.1) 2.4 123 108 41 (38.0) 2.6
$refers to the peak epidemic months of the epidemic periods we defined (see methods and Figure 2); January 2008 - span December 2007 to February 2008,
June 2008 – span April 2008 to September 2008, December 2008 – span November 2008 to March 2009, June 2009 – span April 2009 to August 2009,
December 2009 – span November 2009 to January 2010, Mar 2011 – span December 2010 to August 2011. Inter-epidemic period cases were causes observed
outside the above defined epidemic periods and these occurred between March 2010 and October 2010, and October and November 2011.
#refers to the major epidemic peak month.
§The numbers in the respective column of RSV group A and group B include 5 co-infections, thus the number identified and in total are increased by 5 over
numbers of mono-infections referred to in the text. Only Group A viruses were possible to sequence from co-infections hence numbers of Group A sequenced are
also 5 more than for mono-infections alone.
*% Percentage of total group A and B identified that were group A.
¶refers to the average % genetic distance between the unique sequences which represent the % of nucleotide changes per every 100 nucleotides in the region
between any the unique sequences.
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clade included 96% (174/182) of the Dadaab group A
strains. Within this GA2 (2.2) clade there were 4 sub-
branches with a bootstrap support of >60% (coloured red
on Figure 3), but these had limited between branch gen-
etic distance (< 1.5%) and thus could not be assigned into
further distinct clades. Nevertheless, these well-supported
branches within GA2 (2.2) clade contained sequences
mostly from a single epidemic (Figure 3 and Table 2), and
thus probably represent a transmission cluster within a
clade.0
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Figure 2 Monthly cases of RSV group A and group B in Dadaab from
points are joined by a black continuous line while group B data points are
15 cases per month which was used to distinguish major from minor epidGenetic diversity and clustering of the dadaab group B
strains
Among the sequenced 108 Dadaab RSV group B strains,
41 gave a unique sequence over the 729-nucleotide long
region of overlap in the G gene (nucleotide position 235
to 902 in reference strain CH18537, accession number
M17213). All these group B Dadaab sequences were
found to possess BA 60-nucleotide duplication and add-
itionally showed the presence of a 6-nucleotide deletion
within the first hypervariable region of the G gene. The
mean genetic distance for the group B Dadaab dataset inonth
September 2007 through November 2011. RSV group A data
joined by a grey dashed line. The horizontal dot-dashed line marks
emics.
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Figure 3 A Maximum Likelihood tree showing the relatedness of the unique 52 RSV A Dadaab sequences. Eight reference sequences
within the previously identified RSV A genotypes (GA1-GA7 and SAA1) are included on the tree to allow determination of the genotypes of the
Dadaab strain. Dadaab sequence taxon names are preceded by unfilled triangles. The tree was bootstrapped with 1000 iterations and only
bootstrap support values ≥60 are shown. The clades identified within the GA2 genotype have been indicated on the tree as GA2 (2.1) and GA2
(2.2). The red branches identify those supported by a >60% bootstrap but did not meet the minimum genetic distance to be assigned into
independent clades. Taxon names include country name/unique strain identifier/date of sampling.
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2.6%, respectively. Similar to group A strains, the per-
centage of unique samples was negatively associated
with sequence number (Table 1).
The phylogenetic relationship of the 41 unique Dadaab
group B sequenced strains is shown in Figure 4. The
analysis identified 6 branches with bootstrap support
values >60% (indicated by vertical bars in Figure 4).However, of these only 4 had >1.5% genetic distance from
other branches and were assigned into clades named BA
(2.1) through BA (2.4) (see Figure 4). Of these, BA (2.1)
clade showed most diversification (Figure 4) with a within
clade mean genetic distance of 1.3% and 3 of its sub-
branches had a bootstrap support of 60%. The Dadaab
BA sequences did not cluster with any of the 11 previ-
ously described BA sub-genotypes (BAI-VI, BA7-10 and
Table 2 Distribution of RSV genotypes and clades, by group and epidemic (peak month), Dadaab, NE Kenya
Peak Month$ Jan 2008 Jun 2008 Dec 2008 Jun 2009 Dec 2009 Mar 2011 Inter-epidemic♮
RSV group A
GA2 (2.1) 2 3 0 0 0 0 1
GA2 (2.2)♭ 1 17 66 24 52 8 6
Sub-Branch 1 0 0 4 7 0 0 0
Sub-Branch 2 0 0 0 0 0 8 0
Sub-Branch 3 0 0 1 2 0 0 0
Sub-Branch 4 0 0 0 0 52 0 0
GA5 0 2 0 0 0 0 0
RSV group B
BA (2.1) 0 0 0 1 0 19 4
BA (2.2) 21 0 0 0 0 1 0
BA (2.3) 0 0 0 0 0 55 0
BA (2.4) 0 0 0 0 0 0 2
BA uncladed 3 0 0 1 0 1 0
Total 27 22 66 26 52 84 13
$The epidemic periods of the peaks are defined in Table 1 footnotes.
♮Inter-epidemic period refers to cases that were observed outside defined epidemic periods.
♭The sub-branches within GA2 (2.2) and the number of the sequences that fell under them are shown in italics in the corresponding row.
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below).
The prevalence of the identified Dadaab group A and
B genotypes and clades by epidemic peak is summarized
in Table 2. Note that the sub-branch diversity for GA2
(2.2) clade was epidemic-specific whereas the diversity
for BA 2.1 was within epidemic (Figures 3 and 4).Global phylogeography and diversity of RSV A strains
during the period
From the 649 RSV group A comparison sequences col-
lected over the period 2006–11, we determined that glo-
bally 2 group A genotypes were circulating (GA2: 509,
78.4% and GA5: 140, 21.6%), and both were observed in
Dadaab (Figure 5 and Table 3). A GA2 variant contain-
ing a 72 nucleotide duplication, the ON1 strain, was ob-
served in Canada [23] and Malaysia [24] in 2011 that
was absent from all other countries. Within the GA2,
there was more diversity (~7 clades) than that observed
at Dadaab (2 clades) (Figure 5). But consistent with the
observations at Dadaab, the (2.2) clade (NA1) within the
GA2 genotype was the most prevalent during this period
globally (343/649, 52.9%) and had limited diversity. The
Dadaab minority GA2 (2.1) clade strains represented
3.5% (23/649) in the global dataset and were observed in
South Africa, Germany, Iran, and Netherlands. The 6
Dadaab GA2 (2.1) might have arrived in the camp from
different sources because they occurred as 3 groups
sandwiched between sequences of different countries
(Additional file 2: Figure A1).The 140 GA5 sequences observed in the comparison
dataset (versus 2 for Dadaab) were considerably diversi-
fied (see Figure 5) showing the presence of multiple well
supported clades within (~11). The 2 Dadaab sequences
fell into one of these clades that also contained sequences
from Germany and Croatia. However, the Dadaab se-
quences still occurred on a sub-branch within the clade
that was supported with bootstrap >70%, thus may not have
been directly introduced from these countries (Additional
file 3: Figure A2). Further information on the phylogenetic
temporal clustering of Dadaab group A strains with
the global dataset is described in a BEAST plot in
Additional file 4: Figure A3.
Global phylogeography and diversity of RSV B strains
during the period
From the 505 RSV group B comparison dataset, 4 group
B genotypes were observed during the period (BA: 474,
93.9%, GB2: 12, 2.4%, SAB4: 12, 2.4%, GB3: 7, 1.4%) but
only the BA genotype was identified at Dadaab (Table 3).
The phylogenetic relationships of all the Dadaab RSV B
sequences together with the comparison dataset se-
quences are shown in Figure 6. Of the 4 defined Dadaab
clades, only 2 were observed in other countries, namely
BA (2.1) – Latvia, Great Britain, and Iran, and for BA
(2.2) – India, Kenya, and Korea. However, within BA
during the period, several clades were circulating, most
of which never occurred in Dadaab (Figure 6). Further
information on the phylogenetic temporal clustering of
Dadaab group B strains with the global dataset is de-
scribed in a BEAST plot in Additional file 5: Figure A4.
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KEN/DHH0634/27-02-2008
KEN/DHE0146/29-01-2008
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KEN/DHH2746/04-01-2011
KEN/DHE1499/04-10-2011
KEN/DHE1419/25-07-2011
KEN/DHE1376/07-06-2011
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KEN/DHH3213/01-08-2011
KEN/DHE1527/01-11-2011
KEN/DHE1308/11-03-2011
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KEN/DHE1262/08-02-2011
KEN/DHE1508/11-10-2011
KEN/DHH1701/24-06-2009
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Arg/3997/1999
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0.01
Figure 4 A Maximum Likelihood tree showing the relatedness of the unique 41 RSV B Dadaab sequences. Eight reference sequences
representative of the 8 previously recognized RSV B genotypes (GB1-GB4, SAB1-3, and BA) are included on the tree to allow classification of the
Dadaab strains into these genotypes. The Dadaab sequence taxon names are preceded by unfilled triangles. The tree was bootstrapped with
1000 iterations and only bootstrap support values ≥60 are shown. The clades identified within the BA genotype have been indicated on the tree
(BA (2.1)-BA (2.4). The red branches identify those supported by a >60% bootstrap but did not meet the minimum genetic distance to be
assigned into independent clades. Taxon name includes country name/unique strain identifier/date of sampling.
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This is the first report to describe RSV molecular epidemi-
ology in a displaced population. The study characterizes
the pattern of circulating RSV groups A and B genotypes,
expanding the limited prior data for Kenya [25-27], and
provides a phylogenetic analysis of the observed viral di-
versity in relation to worldwide circulating viruses. The
study was motivated by the unusual biannual epidemic
pattern in the Dadaab camp and whether this might be ex-
plained in the characteristics of the RSV genetic diversity.Results show that of the 6 RSV epidemic peaks that
occurred in Dadaab refugee camp from September 2007
through November 2011, 4 were predominated by group
A consecutively, in a series of minor-major-minor-major,
while the remaining 2, at either ends of the group A
period, were predominated by RSV B. Though spanning
only 5 calendar years, these observations are nevertheless
unusual. Previous reports of biannual epidemics (e.g.
Finland [28], Croatia [29], Switzerland [30], and Germany
[31]) have involved alternating long and short inter-epidemic
Figure 5 (See legend on next page.)
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Figure 5 A Neighbor-joining phylogenetic tree showing the relationships of all RSV A GenBank sequences (649) that we processed for
the period 2006–11 combined with the Dadaab sequence data (182). Sequences are compared in the second hyper-variable region of the G
gene. The Dadaab sequences are indicated by the coloured triangles; their respective colours indicate the year of detection: maroon: 2007, pink:
2008, green: 2009, blue: 2010, red: 2011. The red arrows point to the nodes (or branches) that bring together sequences of the same genotype or
clade identified at Dadaab and the number (n) indicates the number of sequences that fall within that branch. Tips without a triangle imply that
the sequence was observed somewhere other than Dadaab. The tree is bootstrapped with 1000 iterations and whenever the percentage was
greater than 60, the value is indicated next to the branch.
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riods were constant between the first 5 of the 6 peaks.
Furthermore, the observation of 4 consecutive RSV A
epidemics is at variance with previously reported time
series [8-10,28] with pairs of epidemics of one group al-
ternating between A and B. Nonetheless, our molecular
analysis now extending to G variants within the group
strains does support the previous observations by
Mlinaric-Galinovic et al., 2009 and 2012 in Croatia that
virus diversity does not appear to be the driver of the
unusual epidemic patterns [32,33].
Examining data from other geographical locations
within Kenya [34] what is observed in Daadab could rep-
resent overlapping epidemiology from two regions with
differing seasonal patterns. RSV epidemics peak at the
Kenyan Coast and in the Western Kenya regions in Feb-
March and in June-August, respectively. The minor and
major peaks in Daadab seem to coincide with the peaks
in the Western and Coastal regions, respectively. It
would be of interest to look at the similarities of viruses
from each location and epidemic to establish whether
the unusual epidemic patterns in Daadab result from im-
portation of viruses from other epidemiologically distinct
regions in Kenya. Future work would also investigate if
the RSV patterns in Dadaab can be explained by vari-
ation in seasonal forcing as has been shown for annual
and biennial patterns analysed using a transmission dy-
namic model [10], or whether other factors (for example,
birth rates and climatic factors) are necessary to account
for biannual epidemics.
The G gene analysis showed that 3 RSV genotypes cir-
culated in the Dadaab camp during our surveillance
period (GA2: 62.1%, GA5: < 1% and BA: 37.2%) inTable 3 Comparison of the global and Dadaab, Kenya datase
RSV group
Global
Period (years) 2006-11
Total Sequences@ 649
Overall % Genetic distance 6.9
Sequences Unique (%)* 338 (52.1)
Number of genotypes identified 2
@Sequences cover the the 2nd hypervariable region of the G gene.
*The % refers to the sequences unique from the total sequences under the categorqualitative agreement with the proportions observed in
the GenBank comparison dataset (GA2: 44.1%, GA5:
12.1%, and BA: 41.1%). Other genotypes within RSV
group B circulated elsewhere (GB2, GB3, SAB4) [35-37]
but with considerably lower occurrence. The 4 consecu-
tive RSV group A epidemics at Dadaab were almost ex-
clusively GA2 genotype strains and were comprised of
only 2 clades, GA2 (2.1) and GA2 (2.2), with the latter
dominant (174/180, 96.6%). Although 7 clades occurred
within the GA2 globally during this time frame, the GA2
(2.2) clade constituted the larger proportion of se-
quences within GA2 (343/509, 67.4%).
For both RSV group A and B, specimens collected at
Dadaab during the same epidemic peak had limited di-
versity (Figures 3, 4 and Table 1). Overall, only 34.1%
(62/182) of group A and 38.0% (41/108) of group B in-
fections that were sequenced during the entire surveil-
lance period gave unique sequences in the ectodomain
G gene regions, and this further reduced to 21.4% (39/
182) and 22.2% (24/108), respectively, when only the
second hypervariable region of the G gene was consid-
ered (Table 3). This finding suggests that the frequency
of new strain introductions into the camp may not have
been high compared to stable populations, but that epi-
demics were associated with marked spread from small
numbers of introduced or persisting virus strains. An al-
ternative explanation is that the resolution offered by
RSV sequencing of the G ectodomain alone was not ad-
equate to distinguish closely related viruses that were ar-
riving in the camp from different sources or at multiple
times.
While Dadaab camp experienced a biannual epidemic
pattern [3], in Kilifi District, located on the Indiants for RSV groups A and B
A RSV group B
Dadaab Global Dadaab
2007-11 2006-11 2007-11
182 504 108
1.4 4.7 2.4
39 (21.4) 361(71.6) 24 (22.2)
2 4 1
y.
Figure 6 A Neighbor-joining global phylogenetic tree showing the relationships of all the RSV B GenBank sequences (505) that we
processed for the period 2006–11 and the Dadaab sequence data (108), i.e., a total of 613. Sequences are compared in the second
hyper-variable region of the G gene. The Dadaab sequences are indicated by the coloured triangles; their respective colours indicate the year
of detection: maroon: 2007, pink: 2008, green: 2009, blue: 2010, red: 2011. The red arrows point to the nodes (or branches) that bring together
sequences of the same genotype or clade identified at Dadaab and the number (n) indicates the number of sequences that fall within that
branch. Tips without a triangle imply that the sequence was observed somewhere other than Dadaab. The tree was bootstrapped with 1000
iterations and whenever the percentage was greater than 60 the value is indicated next to the branch.
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clearly annual [38]. Epidemics in Kilifi begin around
November, coincident with the start of the major RSV
epidemic season in Dadaab. Furthermore, over the study
period the yearly group dominance pattern did not
match for the two locations. For example, the major epi-
demic in Dadaab spanning the end of 2009 to early 2010
was almost entirely group A, whereas in Kilifi the epi-
demic of 2009–10 the two groups were co-dominant
(Nokes et al., manuscript in preparation). These observa-
tions provide some evidence that RSV epidemics in
Kenya are more regional than national as was observed
for communities across distinct geographical locations in
North America [39].
Notably, Dadaab camp did experience large in-migration
during the surveillance period, in particular from 2006
through 2011, the camp population grew from less than
130,000 to almost 500,000 (JAA, personal communication)
[4]. Given that the genetic variability of the virus in Dadaab
was not greater than that observed globally, coupled with
the observation that RSV group A strains were responsible
for 4 epidemic peaks occurring sequentially, it is possible
that higher rates of buildup of susceptible individuals or
population density may have caused the unusual epidemi-
ology observed. Investigations to elucidate the relative
roles of genetic variability, waning immunity, and dens-
ity of susceptible individuals within a population re-
quired for sustained recurrent epidemics of RSV will
inform on mechanisms of RSV persistence.
This study is not without limitations. Firstly, the sur-
veillance data described here were available over only
5 years, which is probably too short to display the
underlying periodicities of RSV and its genetic variants.
Secondly, not all eligible ILI and SARI patients were en-
rolled for screening, and only samples with a CT value
of ≤ 30 were selected for sub-typing and sequencing.
These could potentially allow under-detection of certain
genotypes if their clinical manifestations were unique or
if they had lower viral loads during peak infection.
Thirdly, the phylogeography analyses, though represent-
ing one of the largest RSV datasets compared to date
[40], are limited by the absence of comparison sequence
data from throughout Kenya, the East Africa region and
elsewhere on the continent. Furthermore, sequences
from most other parts of the world include only a short
fragment of the G gene and this reduces the phylogen-
etic signal when researchers are trying to resolve the ori-
gins of detected strains.
Conclusion
In conclusion, we present the results of the first-ever
study of RSV molecular epidemiology in a displaced
population that also displayed an unusual epidemic pat-
tern. We compare strains from these epidemics and withcirculating genotypes within a large dataset compiled from
22 countries. Over a period spanning 5 calendar years, we
observed that RSV genotypes circulating in the camp were
similar to those identified to be co-circulating over the
same period in stable populations but showed a reduced
genetic variability within genotypes. Strain diversity did
not seem to be the driving force behind observed unusual
transmission patterns in the camp. Investigations are on-
going to assess whether the unusual epidemiologic pat-
terns are associated with the changes in population size
and in-migration.
Additional files
Additional file 1: Additional material. Examining strain diversity and
phylogeography in relation to an unusual epidemic pattern of respiratory
syncytial virus (RSV) in a long-term refugee camp in Kenya.
Additional file 2: Figure A1. Illustrates that within GA2 (2.1) where
there is some diversity, Dadaab experienced probably 3 separate
introductions for the 6 sequences seen (identified by triangle markers:
pink, year 2008; blue, year 2010).
Additional file 3: Figure A2. Illustrates the cluster within which
Daadaab GA5 fell. The clusters contain sequences from Germany (DEU)
and Croatia (HRV). The sequences cluster into 2 main groups with >70%
boostrap support, illustrating that sequences might have not come
directly from these countries and that these sequences are seen about
one year earlier than those from Dadaab (pink triangles, year 2008).
Additional file 4: Figure A3. A time-resolved maximum clade credibility
BEAST tree showing the phylogenetic relationship of the unique RSV A
sequences from Dadaab and the unique RSV A sequences from 16 other
countries collected from 2006-2011. The taxa are coloured by the continent
in which the sequences were sampled. The 16 countries included are Brazil
(BRA), Canada (CAN), China (CHI), Croatia (HRV), Germany (DEU), Great Britain
and Northern Ireland (GBR), Hong Kong (HKG), India (IND), Iran (IRN), Japan
(JPN), Latvia (LVA), Malaysia (MYS), Netherlands (NLD), South Africa (ZAF),
Thailand (THA), and South Korea (KOR). The clades identified in Dadaab are
coloured in red. The taxon nomenclature includes three-letter abbreviation
for the country of sampling/accession number/strain name.
Additional file 5: Figure A4. A time resolved BEAST phylogenetic tree
showing the relationship of the unique RSV B sequences from Dadaab
and the unique RSV B sequences from 18 other countries collected from
2006-2011. The taxa are coloured by the continent the sequences were
sampled. In addition to Kenya, the 18 other countries included are Brazil
(BRA), China (CHI), Croatia (HRV), Great Britain and Northern Ireland (GBR),
Hong Kong (HKG), India (IND), Iran (IRN), Japan (JPN), Latvia (LVA),
Malaysia (MYS), Netherlands (NLD), South Africa (ZAF), Thailand (THA),
Cambodia (KHM), Spain (ESP), Ireland (IRL), Vietnam (VNM), and South
Korea (KOR). The Dadaab sequences are coloured in red, Kilifi in black.
The taxon nomenclature includes three-letter abbreviation for the country
of sampling/accession number/strain name.
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